Get the Stockscreener App
0.45
13.46%
-0.07
After Hours:
.44
-0.01
-2.22%
Onconetix Inc stock is traded at $0.45, with a volume of 1.37M.
It is down -13.46% in the last 24 hours and down -70.59% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
See More
Previous Close:
$0.52
Open:
$0.481
24h Volume:
1.37M
Relative Volume:
0.20
Market Cap:
$5.16M
Revenue:
$815.40K
Net Income/Loss:
$-14.03M
P/E Ratio:
-0.0017
EPS:
-264.0465
Net Cash Flow:
$-9.68M
1W Performance:
-38.19%
1M Performance:
-70.59%
6M Performance:
-96.63%
1Y Performance:
-98.47%
1-Day Range:
$0.4313
$0.4843
1-Week Range:
$0.4313
$0.6945
52-Week Range:
$0.4313
$74.29
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
0.45 | 5.96M | 815.40K | -14.03M | -9.68M | -264.05 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Onconetix Inc Stock (ONCO) Latest News
Onconetix Stock Short Interest Falls to 33.12% - Quiver Quantitative
Onconetix Shareholders Approve Flexible Reverse Stock Split Authorization - TipRanks
Onconetix (NASDAQ: ONCO) investors back reverse stock split, adjournment - Stock Titan
Onconetix Inc (ONCO) - MSN
Onconetix stock skyrockets after Realbotix ships Vinci-equipped robot to Ericsson - MSN
Onconetix (NASDAQ: ONCO) files S-1 for 25M-share Keystone equity line resale - Stock Titan
Onconetix announces 1-for-5 reverse stock split - MSN
Small-Cap Stocks Under $1: DVLT, PRSO, USEG, ONCO, TOON See Volume Surge Amid Major Catalysts - FinancialContent
Trending Stocks Today | Onconetix Surges 37.75% Pre-Market - Moomoo
Onconetix Reshapes Board Leadership With New Chairman, Director - The Globe and Mail
Onconetix (ONCO) Proxy Filing Summary - Quartr
Onconetix, Inc. Files 8-K Report: Company Details, NASDAQ Listing, Emerging Growth Status, and Executive Information - Minichart
Onconetix announces board changes and new appointments By Investing.com - Investing.com India
Onconetix announces board changes and new appointments - Investing.com
Onconetix Inc Andrew Oakley Resigns As Chairman Of Board - TradingView
Onconetix appoints Josh Epstein to board; Sammy Dorf named chairman - TradingView
Board changes at Onconetix (NASDAQ: ONCO) add new chair and director - Stock Titan
ONCO Stock: HRT Financial LP Sells 49,710 Shares on April 21 - Meyka
Onconetix Inc. Posts $815B Revenue, $0.25 EPS No Prior EstimatesDividend Growth - Cổng thông tin điện tử tỉnh Lào Cai
HRT Financial sells $34,299 of Onconetix (NASDAQ:ONCO) stock By Investing.com - Investing.com South Africa
HRT Financial sells $34,299 of Onconetix (NASDAQ:ONCO) stock - Investing.com
Ten percent holder HRT Financial cuts Onconetix (ONCO) stake - Stock Titan
Onconetix: HRT financial, 10% owner, sells $110,169 in stock By Investing.com - Investing.com Australia
Onconetix: HRT financial, 10% owner, sells $110,169 in stock - Investing.com
HRT Financial LP trims Onconetix (ONCO) stake with net share sales - Stock Titan
What's going on with Onconetix shares on Friday? - MSN
Hrt financial buys Onconetix (ONCO) shares worth $127590 By Investing.com - Investing.com Australia
Hrt financial buys Onconetix (ONCO) shares worth $127590 - Investing.com
HRT Financial LP boosts Onconetix (ONCO) stake with open-market share buys - Stock Titan
HRT FINANCIAL LP (ONCO) discloses 104,498 Class A Shares in Form 3 - Stock Titan
Onconetix Stock Short Interest Rises to 98.42% - Quiver Quantitative
Onconetix Faces Market Shift Amid Strategic Stock Move - timothysykes.com
IX Acquisition Corp. (IXAQ) - Minichart
Pullback Watch: Does Onconetix Inc have a sustainable dividend2026 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Onconetix Advances in Robotics Through Key Acquisition Deal - StocksToTrade
Trending Stocks Today | Onconetix Soars 53.98% - Moomoo
Check out the stocks that are attracting the most attention and driving market activity. - ChartMill
Onconetix (ONCO) jumps 59% as reverse-split dynamics and Realbotix deal keep speculation elevated - Quiver Quantitative
Onconetix Stock Skyrockets After Realbotix Ships Vinci-Equipped Robot To Ericsson - Benzinga
Crude Oil Surges 3%; Neogen Shares Fall After Q3 Results - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):